Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-LILLY-PRADHAN-JGDN
StatusOPEN TO ACCRUAL
Principal InvestigatorPradhan, Kamnesh
ScopeNational
PhasePhase I
Age GroupChildren
TitleI5B-MC-JGDN(a) A Phase 1, Open-Label, Dose-Escalation Study of Olaratumab as a Single Agent and in combination with Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients with Relapsed or Refractory Solid Tumors
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu